Literature DB >> 11096758

Transient Ischemic Attack and Secondary Stroke.

.   

Abstract

Transient ischemic attack (TIA) is a clinical syndrome that has been shown to be a major risk factor for stroke. Patients with transient neurologic deficits of sudden onset that last less than 24 hours require prompt medical and neurologic evaluation for identifiable stroke risk factors. The appropriate treatment depends on the cardio- or neurovascular lesion that caused the TIA. Based on this evaluation, the optimal stroke prevention regimen in a person with TIA will vary from surgical repair of a stenotic carotid artery to daily aspirin use.

Entities:  

Year:  2000        PMID: 11096758     DOI: 10.1007/s11940-000-0050-x

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  46 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study.

Authors:  R L Sacco; B Boden-Albala; R Gan; X Chen; D E Kargman; S Shea; M C Paik; W A Hauser
Journal:  Am J Epidemiol       Date:  1998-02-01       Impact factor: 4.897

3.  Epidemiology of stroke: emphasis on transient cerebral ischemia attacks and hypertension.

Authors:  J P Whisnant
Journal:  Stroke       Date:  1974 Jan-Feb       Impact factor: 7.914

Review 4.  Oral contraceptives and stroke.

Authors:  W T Longstreth; P D Swanson
Journal:  Stroke       Date:  1984 Jul-Aug       Impact factor: 7.914

5.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

6.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

7.  Risk of stroke in male cigarette smokers.

Authors:  R D Abbott; Y Yin; D M Reed; K Yano
Journal:  N Engl J Med       Date:  1986-09-18       Impact factor: 91.245

8.  Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks.

Authors:  C M Fisher
Journal:  Can J Neurol Sci       Date:  1980-02       Impact factor: 2.104

9.  Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion.

Authors:  R L Grubb; C P Derdeyn; S M Fritsch; D A Carpenter; K D Yundt; T O Videen; E L Spitznagel; W J Powers
Journal:  JAMA       Date:  1998 Sep 23-30       Impact factor: 56.272

10.  The Harvard Cooperative Stroke Registry: a prospective registry.

Authors:  J P Mohr; L R Caplan; J W Melski; R J Goldstein; G W Duncan; J P Kistler; M S Pessin; H L Bleich
Journal:  Neurology       Date:  1978-08       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.